亚洲精品国产成人一区二区_欧美性xxxxx极品娇小_国产欧美久久一区二区三区_日日麻批免费40分钟无码
Home
About
Capabilities
R&D
Investors
News
Careers
中文
Home
About
Capabilities
R & D
Investors
News
Careers
Press Release
Press Release
2024
2023
2022
2021
2020
2019
2018
2017
Dec 19, 2022
Mabwell Was Ranked in the "List of New and Innovative Chinese Pharmaceutical Forces"
?
Dec 01, 2022
Mabwell Published Pre-clinical Study Results of CD47/PD-L1 Bi-specific Antibody 6MW3211
?
Nov 23, 2022
Dr. Liu Datao, Co-founder and CEO of Mabwell, was Honored as “Sci-Tech Innovation Board Leaders,2022”
?
Nov 22, 2022
Mabwell and Junshi Announce the Approval of Five Indications for Adalimumab
?
Nov 21, 2022
Mabwell Announces the U.S. FDA approval of 9MW3011 (FIC) for IND
?
Nov 18, 2022
Dr. Liu Datao, CEO of Mabwell, Was Invited to Participate in the Live Interview of "International Biopharma Industry Week Shanghai 2022" by Yicai
?
Nov 16, 2022
Mabwell Awarded "Zhangjiang Life Science Industry New Prominent · 2022"
?
Nov 11, 2022
Mabwell Ranked the List of Top 20 Most Influential Antibody Pharmaceutical Companies in China 2022
?
Oct 21, 2022
Wu Zhiyuan, Director of Development Research Center of People's Government of Pudong New Area, and His Entourage Visited Mabwell for Research and Guidance
?
Oct 19, 2022
First in Class! Mabwell's Clinical Trial Application for 9MW3011 Injection - An Innovative Drug Accepted by NMPA
?
1
2
3
Next
主站蜘蛛池模板:
马关县
|
宿松县
|
即墨市
|
察雅县
|
五指山市
|
福州市
|
咸宁市
|
什邡市
|
宁武县
|
怀柔区
|
濉溪县
|
云龙县
|
临澧县
|
安达市
|
九江县
|
侯马市
|
淳化县
|
松潘县
|
凤冈县
|
浦北县
|
灵台县
|
伊金霍洛旗
|
宜章县
|
西乌珠穆沁旗
|
建瓯市
|
潞西市
|
庄河市
|
师宗县
|
乌拉特中旗
|
清新县
|
营口市
|
大石桥市
|
凤冈县
|
眉山市
|
文安县
|
汤原县
|
彭州市
|
陈巴尔虎旗
|
南郑县
|
永定县
|
左云县
|